Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Genital Neoplasms, Female × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 142 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Recurrence 23 Vomiting 22 Leukemia 22 Neoplasms, Plasma Cell 17 Neoplasms 16 Lymphoma 16 Nausea 12 Burkitt Lymphoma 9 Prostatic Neoplasms 8 Immunoglobulin Light-chain Amyloidosis 7 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Hodgkin Disease 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Follicular 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Paraproteinemias 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3 Smoldering Multiple Myeloma 2 Plasmacytoma 2

Interventions

Gemcitabine 2 liposomal doxorubicin 1 fosaprepitant 1 argatroban 1 Palonosetron 1 Paclitaxel 1 Heparin, Low-Molecular-Weight 1 Drug Therapy 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01074697 2015-04-24

GAND-emesis

Odense University Hospital

Phase 3 Completed

Genital Neoplasms, Female, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡